Association of Emergency Department Pediatric Readiness With Mortality to 1 Year Among Injured Children Treated at

Craig D Newgard1, Amber Lin1, Jeremy D Goldhaber-Fiebert2

  • 1Center for Policy and Research in Emergency Medicine, Department of Emergency Medicine, Oregon Health & Science University, Portland.

JAMA Surgery
|February 2, 2022
PubMed

Insights

High pediatric readiness in emergency departments (EDs) is linked to better survival for injured children. Trauma centers with higher pediatric readiness scores show improved 1-year survival rates for children after injury.

Area of Science:

  • Pediatric Emergency Medicine
  • Trauma Care
  • Public Health Outcomes

Background:

  • Emergency departments (EDs) show significant variability in their preparedness for pediatric emergencies.
  • High pediatric readiness in EDs is associated with improved in-hospital survival for children in trauma centers.
  • The long-term survival impact of ED pediatric readiness remains largely unknown.

Purpose of the Study:

  • To investigate the association between emergency department pediatric readiness and 1-year survival.
  • To analyze outcomes for injured children presenting to 146 trauma centers.

Main Methods:

  • Retrospective cohort study including injured children (<18 years) from 8 states.
  • Utilized data from 146 trauma centers (2012-2017), with 1-year follow-up.
  • Pediatric readiness measured by the weighted Pediatric Readiness Score (wPRS); primary outcome was 1-year mortality.

Main Results:

  • 88,071 children were included; 2.2% died within 1 year.
  • Children in the highest wPRS quartile (95-100) had a 30% lower hazard of 1-year death compared to the lowest quartile (32-69).
  • Findings remained consistent across subgroups and sensitivity analyses.

Conclusions:

  • Higher pediatric readiness in trauma center EDs is associated with reduced mortality risk for injured children.
  • This association persists up to 1 year post-injury.
  • High ED pediatric readiness is an independent predictor of improved long-term survival in pediatric trauma patients.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
106
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
11